-
Mashup Score: 0
The evolution of treatment for hepatitis C virus during the past 15 years has been astounding, and we now are able to talk about how HCV could be eliminated.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 4Current and Emerging Treatments for Autoimmune Hepatitis – Gastroenterology & Hepatology - 10 day(s) ago
Ethan M. Weinberg, MD, MS Assistant Professor of Clinical Medicine Division of Gastroenterology and Hepatology University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania G & H What is the current understanding of autoimmune hepatitis and its pathogenesis? EW Autoimmune hepatitis (AIH) is a composite of diseases marked by immune dysregulation targeting hepatocytes in the absence of infection. This immune dysregulation leads to inflammation in the liver. Clinically, this is seen as
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Let's Call March Hepatitis Education Month - 27 day(s) ago
In thinking about the international and national public health campaigns to eliminate hepatitis, is general awareness of the disease enough to motivate treatment-hesitant hepatitis patients to accept clinical care, or does there need to be a greater commitment beyond that?
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients - 1 month(s) ago
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. “Alcohol-associated hepatitis (AH) is the most severe form of liver disease on the spectrum of alcohol-associated liver disease (ALD) with high short- and long-term mortality and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients - 1 month(s) ago
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. “Alcohol-associated hepatitis (AH) is the most severe form of liver disease on the spectrum of alcohol-associated liver disease (ALD) with high short- and long-term mortality and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients - 1 month(s) ago
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. “Alcohol-associated hepatitis (AH) is the most severe form of liver disease on the spectrum of alcohol-associated liver disease (ALD) with high short- and long-term mortality and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
Results highlight the benefit of achieving sustained virological response with DAAs for decreasing patients’ risk of carotid atherosclerosis and peripheral artery disease, especially among those with severe fibrosis.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 20A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis - 2 month(s) ago
This patient’s case history (void of protected health information) was discussed in a multidisciplinary meeting including hepatologists (LD, MG), a pathologist (DK), an immunologist (EP) with NC as moderator. We summarize the case history and discussion in the following article.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Investigational HCV Therapy Demonstrates 98% Sustained Virologic Response at Week 4 - 2 month(s) ago
Atea Pharmaceuticals announced topline data from their phase 2 trial showing a higher than expected efficacy for the study.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 4A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy - 3 month(s) ago
Data on the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) in migrants living in Italy are scanty,1 and there are few screening and linkage-to-care programs for this target.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
From our issue: Dr. Lauren Hynicka discusses the evolution of treatment for #hepatitis C over the last several years, and how we are now able to talk about how HCV could be eliminated. https://t.co/hMkd6baAeL https://t.co/ayH1xOE5zR